We first tested whether DNP hapten-specific antibodies can be recruited to B16.F10 melanoma tumor cells engineered to express a mutant human PSMA that has a deletion in its cytoplasmic domain (ΔPSMA) to prevent its internalization upon ligand binding23. Here, FOLH1 is linked to neoplasm.